Analyst Price Targets — LFVN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 1:47 pm | Brooks O'Neil | Loop Capital Markets | $5.00 | $4.54 | StreetInsider | Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets |
| February 5, 2026 1:45 pm | — | Lake Street | $5.00 | $4.60 | TheFly | LifeVantage price target lowered to $5 from $12 at Lake Street |
| November 5, 2025 2:10 pm | Ryan Meyers | Lake Street | $12.00 | $7.03 | TheFly | LifeVantage price target lowered to $12 from $30 at Lake Street |
| January 14, 2025 12:42 pm | Alex Fuhrman | Craig-Hallum | $35.00 | $16.45 | TheFly | LifeVantage initiated with a Buy at Craig-Hallum |
| January 10, 2025 1:44 pm | Brooks O'Neil | Lake Street | $30.00 | $22.52 | TheFly | LifeVantage price target raised to $30 from $26 at Lake Street |
| December 19, 2024 1:17 pm | Brooks O'Neil | Lake Street | $26.00 | $14.60 | TheFly | LifeVantage initiated with a Buy at Lake Street |
Latest News for LFVN
LifeVantage (NASDAQ: LFVN) reported fiscal second-quarter 2026 results that reflected a sharp year-over-year decline in revenue and earnings as the company cycled the prior-year launch of its MindBody GLP-1 System and faced intensifying competition in the broader GLP-1 category. Management also highlighted early momentum from the LoveBiome acquisition, new product launches, and a major new share
LifeVantage Corporation (LFVN) Q2 2026 Earnings Call Transcript
Lifevantage (LFVN) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.22 per share a year ago.
SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of…
SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April, 2026. Fife will continue in…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFVN.
U.S. House Trading
No House trades found for LFVN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.